Estonsko - estonština - Ravimiamet

dolorgiet gmbh & co. kg - ibuprofeen - kreem - 50mg 1g 50g 1tk; 50mg 1g 150g 1tk; 50mg 1g 100g 1tk

Evropská unie - estonština - EMA (European Medicines Agency)

viiv healthcare b.v. - dolutegravir naatrium, lamivudine - hiv-nakkused - viirusevastased ravimid süsteemseks kasutamiseks - dovato on näidustatud ravi inimese immuunpuudulikkuse viirus tüüp 1 (hiv-1) nakkuse täiskasvanud ja noorukid üle 12 aastased, mis kaalub vähemalt 40 kg, ei ole teada või kahtlustatakse vastupanu integrase inhibiitorite klassi, või lamivudine.

Evropská unie - estonština - EMA (European Medicines Agency)

viiv healthcare bv - dolutegravir - hiv-nakkused - viirusevastased ravimid süsteemseks kasutamiseks - tivicay is indicated in combination with other anti-retroviral medicinal products for the treatment of human immunodeficiency virus (hiv) infected adults, adolescents and children of at least 6 years of age or older and weighing at least 14 kg. tivicay is indicated in combination with other anti-retroviral medicinal products for the treatment of human immunodeficiency virus (hiv) infected adults, adolescents and children of at least 4 weeks of age or older and weighing at least 3 kg.

Evropská unie - estonština - EMA (European Medicines Agency)

viiv healthcare b.v. - dolutegravir naatrium, rilpivirine vesinikkloriid - hiv-nakkused - viirusevastased ravimid süsteemseks kasutamiseks - juluca on näidustatud ravi inimese immuunpuudulikkuse viirus tüüp 1 (hiv-1) nakkuse täiskasvanuid, kes on virologically-allasurutud (hiv-1 rna.

Evropská unie - estonština - EMA (European Medicines Agency)

viiv healthcare b.v. - dolutegravir sodium, lamivudine, abacavir (as sulfate) - hiv-nakkused - viirusevastased ravimid süsteemseks kasutamiseks - triumeq is indicated for the treatment of human immunodeficiency virus (hiv) infected adults,  adolescents and children  weighing at least 25 kg who are antiretroviral treatment-naïve or are infected with hiv without documented or clinically suspected resistance to any of the three antiretroviral agents in triumeq.

Evropská unie - estonština - EMA (European Medicines Agency)

pinnacle biologics b.v.  - porfimer naatrium - barrett söögitoru - antineoplastilised ained - photodynamic ravi (pdt) photobarr on näidustatud: ablatsiooni kõrge-klassi dysplasia (hgd) patsientidel barrett on söögitoru (bo).

Evropská unie - estonština - EMA (European Medicines Agency)

dr. falk pharma gmbh - budesonide - söögitoruhaigused - antidiarrheals, soole põletikuvastased / antiinfective ained - jorveza on näidustatud eosinofiilse ösofagiidi (eoe) raviks täiskasvanutel (vanematel kui 18-aastastel).

Evropská unie - estonština - EMA (European Medicines Agency)

novartis europharm limited - vildagliptin, metformiin vesinikkloriid - suhkurtõbi, tüüp 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - eucreas is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.

Evropská unie - estonština - EMA (European Medicines Agency)

novartis europharm limited - vildagliptin, metformiin vesinikkloriid - suhkurtõbi, tüüp 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 ja 5. 1 erinevate kombinatsioonide kohta kättesaadavate andmete osas).

Evropská unie - estonština - EMA (European Medicines Agency)

novartis europharm limited  - vildagliptin, metformiin vesinikkloriid - suhkurtõbi, tüüp 2 - diabeetis kasutatavad ravimid - zomarist is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate.